![Jennifer Fitzpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Fitzpatrick
Algemeen Adviseur bij
SIONNA THERAPEUTICS, INC.
Vermogen: 339 278 $ op 31-08-2026
Profiel
Jennifer Fitzpatrick is Chief Legal Officer at Sionna Therapeutics, Inc. starting in 2025.
Former positions include Secretary & Director at Aegerion Pharmaceuticals, Inc., Vice President & Corporate Counsel at SAGE Therapeutics, Inc., Corporate Counsel at Revvity, Inc., and Corporate Counsel at AVEO Pharmaceuticals, Inc. Education includes undergraduate studies at Middlebury College and graduate studies at the University of Virginia School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-09-2026 | 56.265 ( 0,12% ) | 339 278 $ | 31-08-2026 |
Actieve functies van Jennifer Fitzpatrick
| Bedrijven | Functie | Begin |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Algemeen Adviseur | 03-06-2024 |
Eerdere bekende functies van Jennifer Fitzpatrick
| Bedrijven | Functie | Einde |
|---|---|---|
| REVVITY, INC. | Algemeen Adviseur | - |
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
| AEGERION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | - |
Opleiding van Jennifer Fitzpatrick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
University of Virginia School of Law
 University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
